240 related articles for article (PubMed ID: 19103472)
1. Detection of circulating tumor cells in bladder cancer patients.
Nezos A; Pissimisis N; Lembessis P; Sourla A; Dimopoulos P; Dimopoulos T; Tzelepis K; Koutsilieris M
Cancer Treat Rev; 2009 May; 35(3):272-9. PubMed ID: 19103472
[TBL] [Abstract][Full Text] [Related]
2. Detection of hematogenous micrometastasis in patients with transitional cell carcinoma.
Güdemann CJ; Weitz J; Kienle P; Lacroix J; Wiesel MJ; Soder M; Benner A; Staehler G; Doeberitz MV
J Urol; 2000 Aug; 164(2):532-6. PubMed ID: 10893639
[TBL] [Abstract][Full Text] [Related]
3. Detection of circulating tumour cells in peripheral blood of patients with advanced non-metastatic bladder cancer.
Rink M; Chun FK; Minner S; Friedrich M; Mauermann O; Heinzer H; Huland H; Fisch M; Pantel K; Riethdorf S
BJU Int; 2011 May; 107(10):1668-75. PubMed ID: 20735381
[TBL] [Abstract][Full Text] [Related]
4. Development of a multiplex RNA urine test for the detection and stratification of transitional cell carcinoma of the bladder.
Holyoake A; O'Sullivan P; Pollock R; Best T; Watanabe J; Kajita Y; Matsui Y; Ito M; Nishiyama H; Kerr N; da Silva Tatley F; Cambridge L; Toro T; Ogawa O; Guilford P
Clin Cancer Res; 2008 Feb; 14(3):742-9. PubMed ID: 18245534
[TBL] [Abstract][Full Text] [Related]
5. PCR- and RT-PCR-based methods of tumor detection: potential applications and clinical implications.
Seiden M; Sklar JL
Important Adv Oncol; 1996; ():191-204. PubMed ID: 8791136
[No Abstract] [Full Text] [Related]
6. Application of immunomagnetic cell enrichment in combination with RT-PCR for the detection of rare circulating head and neck tumor cells in human peripheral blood.
Tong X; Yang L; Lang JC; Zborowski M; Chalmers JJ
Cytometry B Clin Cytom; 2007 Sep; 72(5):310-23. PubMed ID: 17205568
[TBL] [Abstract][Full Text] [Related]
7. [Pathologic anatomy of superficial tumors of the bladder].
Billerey C; Sibony M; Gattegno B; Chopin D
Prog Urol; 2001 Nov; 11(5):805-63. PubMed ID: 11769082
[No Abstract] [Full Text] [Related]
8. The clinical significance of circulating tumor cells in the peripheral blood.
Elshimali YI; Grody WW
Diagn Mol Pathol; 2006 Dec; 15(4):187-94. PubMed ID: 17122646
[TBL] [Abstract][Full Text] [Related]
9. Detection of circulating cancer cells in lung cancer patients with a panel of marker genes.
Liu L; Liao GQ; He P; Zhu H; Liu PH; Qu YM; Song XM; Xu QW; Gao Q; Zhang Y; Chen WF; Yin YH
Biochem Biophys Res Commun; 2008 Aug; 372(4):756-60. PubMed ID: 18514066
[TBL] [Abstract][Full Text] [Related]
10. Analysis of hTERT expression in exfoliated cells from patients with bladder transitional cell carcinomas using SYBR green real-time fluorescence quantitative PCR.
Xie XY; Yang X; Zhang JH; Liu ZJ
Ann Clin Biochem; 2007 Nov; 44(Pt 6):523-8. PubMed ID: 17961306
[TBL] [Abstract][Full Text] [Related]
11. Molecular markers for detection, surveillance and prognostication of bladder cancer.
Vrooman OP; Witjes JA
Int J Urol; 2009 Mar; 16(3):234-43. PubMed ID: 19298346
[TBL] [Abstract][Full Text] [Related]
12. [Mechanisms of tumour cell dissemination and methods for detection of circulating tumour cells in transitional cell carcinoma].
Schilling D; Todenhöfer T; Taran FA; Hartkopf A; Stenzl A; Fehm T
Aktuelle Urol; 2011 Mar; 42(2):122-7. PubMed ID: 21437836
[TBL] [Abstract][Full Text] [Related]
13. The detection of circulating tumor cells of breast cancer patients by using multimarker (Survivin, hTERT and hMAM) quantitative real-time PCR.
Shen C; Hu L; Xia L; Li Y
Clin Biochem; 2009 Feb; 42(3):194-200. PubMed ID: 19022237
[TBL] [Abstract][Full Text] [Related]
14. Detection of disseminated melanoma cells by reverse-transcription - polymerase chain reaction.
Samija I; Lukac J; Kusić Z; Situm M; Samija M
Coll Antropol; 2007 Dec; 31(4):1187-94. PubMed ID: 18217480
[TBL] [Abstract][Full Text] [Related]
15. E-cadherin tissue expression and urinary soluble forms of E-cadherin in patients with bladder transitional cell carcinoma.
Shi B; Laudon V; Yu S; Dong D; Zhu Y; Xu Z
Urol Int; 2008; 81(3):320-4. PubMed ID: 18931551
[TBL] [Abstract][Full Text] [Related]
16. Identification of circulating prostate cancer cells: a challenge to the clinical implementation of molecular biology (review).
Schamhart DH; Maiazza R; Kurth KH
Int J Oncol; 2005 Mar; 26(3):565-77. PubMed ID: 15703810
[TBL] [Abstract][Full Text] [Related]
17. Editorial comment on: molecular lymph node staging in bladder urothelial carcinoma: impact on survival.
Froehner M
Eur Urol; 2008 Dec; 54(6):1371. PubMed ID: 18486320
[No Abstract] [Full Text] [Related]
18. Editorial comment on: molecular lymph node staging in bladder urothelial carcinoma: impact on survival.
Karl A
Eur Urol; 2008 Dec; 54(6):1372. PubMed ID: 18486317
[No Abstract] [Full Text] [Related]
19. [Detection and clinic implication of circulating tumor cell in patients with lung cancer].
Mu XL; Li LY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Jun; 26(3):313-8. PubMed ID: 15266838
[TBL] [Abstract][Full Text] [Related]
20. Expression of survivin and its spliced variants in bladder tumors as a potential prognostic marker.
Nouraee N; Mowla SJ; Ozhand A; Parvin M; Ziaee SA; Hatefi N
Urol J; 2009; 6(2):101-8. PubMed ID: 19472128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
